Willingdon Wealth Management Has $6.85 Million Stake in UnitedHealth Group Inc (NYSE:UNH)

Willingdon Wealth Management boosted its stake in UnitedHealth Group Inc (NYSE:UNH) by 1.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,089 shares of the healthcare conglomerate’s stock after purchasing an additional 431 shares during the period. UnitedHealth Group comprises approximately 1.6% of Willingdon Wealth Management’s investment portfolio, making the stock its 14th biggest position. Willingdon Wealth Management’s holdings in UnitedHealth Group were worth $6,854,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Canton Hathaway LLC bought a new position in shares of UnitedHealth Group during the 1st quarter worth about $36,000. Truvestments Capital LLC bought a new position in shares of UnitedHealth Group during the 1st quarter worth about $42,000. Coastal Capital Group Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter worth about $45,000. Creative Financial Designs Inc. ADV boosted its position in shares of UnitedHealth Group by 89.6% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after purchasing an additional 95 shares in the last quarter. Finally, Capital Advisors Ltd. LLC boosted its position in shares of UnitedHealth Group by 235.7% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock worth $57,000 after purchasing an additional 165 shares in the last quarter. 85.65% of the stock is currently owned by institutional investors and hedge funds.

NYSE:UNH traded up $6.02 on Tuesday, hitting $249.22. The stock had a trading volume of 2,439,421 shares, compared to its average volume of 3,510,335. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62. The firm has a market cap of $235.62 billion, a PE ratio of 19.35, a P/E/G ratio of 1.33 and a beta of 0.61. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The firm’s fifty day simple moving average is $251.38.



UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The firm had revenue of $60.60 billion during the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter last year, the business posted $3.14 EPS. Research analysts expect that UnitedHealth Group Inc will post 14.82 EPS for the current fiscal year.

In other news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $248.00, for a total transaction of $2,480,000.00. Following the completion of the sale, the director now owns 187,663 shares in the company, valued at approximately $46,540,424. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $246.40, for a total transaction of $1,232,000.00. Following the sale, the director now owns 187,979 shares of the company’s stock, valued at approximately $46,318,025.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 37,000 shares of company stock valued at $9,195,620. 0.82% of the stock is currently owned by company insiders.

A number of research firms have recently issued reports on UNH. Oppenheimer set a $312.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Royal Bank of Canada set a $311.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. SunTrust Banks cut their price objective on shares of UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research report on Wednesday, April 17th. They noted that the move was a valuation call. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Finally, Bank of America reaffirmed a “buy” rating and issued a $290.00 price target (down previously from $320.00) on shares of UnitedHealth Group in a research report on Wednesday, April 17th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $295.06.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What is the CBOE Russell 2000® Volatility Index?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.